The named integrins also interact with tyrosine kinase receptors (e.g., EGFR-ERBB2, MST1R/macrophage stimulating 1 receptor, and c-MET/methoprene-tolerant) and their ligands, helping to amplify the oncogenic signaling in tumor cells [215,219]. Here, MST1R is linked to neoplasm.